FDA Adverse Event Injury Summary report: N

LIQUIBAND EXCEED

MDR report key: 11604023 · Received April 1, 2021

Report

Report Number
9617175-2021-00016
Event Type
Injury
Date Received
April 1, 2021
Report Date
May 9, 2021
Manufacturer
ADVANCED MEDICAL SOLUTIONS LTD
Product Code
MPN
PMA / PMN Number
K151182
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

ACCORDING TO THE REPORTER, THE GLUE WAS USED TO SEAL THE INCISIONS. HOWEVER, 2 WEEKS FOLLOWING A REVISION OF RECONSTRUCTION, NIPPLE RECONSTRUCTION, AND MASTOPEXY, THE PATIENT HAD ALLERGIC REACTIONS (DERMATITIS).

Additional Manufacturer Narrative · 1

WE CANNOT CONFIRM OR DENY THAT LIQUIBAND EXCEED CAUSED A SERIOUS INJURY. THERE IS A SMALL PERCENTAGE OF THE POPULATION WITH A NATURAL SENSITIVITY TO CYANOACRYLATE ADHESIVE. THIS IS INDICATED IN THE INSTRUCTIONS FOR USE (IFU).

Description of Event or Problem · 1

SKIN REACTIONS USUALLY NOTICED 2 TO 3 WEEKS AFTER SURGERY. 11 COMPLANTS OVER 2 YEARS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
498459 LIQUIBAND EXCEED TOPICAL SKIN ADHESIVE MPN ADVANCED MEDICAL SOLUTIONS LTD 72014008

Patients

Seq Age Sex Outcome Treatment
1 Other